Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Blockbuster Drug Adds New Indication. More details...
CBT 200 Slides 11 Points Lower. More details...
CBT 200 Suffers Small Loss. More details...
CBT 200 Down A Small 3 Points. More details...
CBT 200 Gains 13 Points. More details...
Company Offers EPO Clone To Chinese Market. More details...
Huge Market; Low Costs. More details...
CBT 200 Stops Downtrend. More details...
CBT 200 Slips 4 Points Lower. More details...
Biotech Off A Fraction. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
